Genmab at Antibody Engineering 2026
Dec 13–16, 2026 San Diego, CA ~900 attendees Website
Genmab takes part in 2 sessions at Antibody Engineering 2026 in San Diego. Its program centers on antibody uses beyond cancer and on engineering the surfaces where antibody chains meet. Its research redesigns the CH3 region where heavy chains pair, so several antibodies can be made together as a polyclonal mix without their chains pairing wrongly.
| Organization | Antibody Engineering 2026 Attendance |
|---|---|
Genmab Copenhagen, Denmark | |
Danish antibody company with marketed cancer medicines, developing bispecific antibodies and antibody-drug conjugates. | Talk Tue Dec 15 2:25pm–2:30pm Talk Wed Dec 16 11:30am–12:00pm Enabling Polyclonal Antibody Production through Fc-engineering of Mutual Exclusive CH3 Interfaces Reshaping the region where two antibody halves join, so several different antibodies can be made together in one mixture without mismatching. |
Instantly find 20 buyers from Genmab
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect, The Antibody Society or Antibody Engineering & Therapeutics. Submit a correction